Author: Miguel Antonatos, MD.
As a physician who has witnessed the profound impact of COVID-19 on patients, it is crucial to shed light on a growing concern: the phenomenon of COVID-19 long-haulers. While the acute phase of COVID-19 is well-documented, the long-term effects of the virus have left many grappling with persistent health issues. In this article, we will provide an in-depth overview of the long-term effects of COVID-19 and explore who is most at risk of becoming a long-hauler. Understanding COVID-19 Long-Haulers: What We Know So Far
I. Defining Long-Haul COVID
Long-haul COVID, often referred to as post-acute sequelae of SARS-CoV-2 infection (PASC), is characterized by the persistence of symptoms well beyond the acute phase of COVID-19. These symptoms can affect multiple organ systems, making it a complex and challenging condition. Common long-haul COVID symptoms include:
- Respiratory Symptoms: Individuals may experience ongoing shortness of breath, chest pain, and a persistent cough.
- Neurological Symptoms: Brain fog, memory difficulties, headaches, and loss of taste or smell are frequently reported.
- Cardiovascular Complications: Some long-haulers face heart palpitations, chest discomfort, and irregular heart rhythms.
- Gastrointestinal Distress: Long-haulers may contend with persistent nausea, diarrhea, and abdominal pain.
- Fatigue and Weakness: Profound fatigue and muscle weakness can severely impact daily functioning.
- Psychological Challenges: Anxiety, depression, and mood swings may accompany physical symptoms, affecting mental well-being.
- Joint Pain: Joint pain and inflammation resembling autoimmune conditions can occur.
II. Who Is Most at Risk?
COVID-19 long-haulers come from diverse backgrounds, and while the condition can affect anyone, certain groups appear to be more susceptible:
- Severity of Initial Infection: Individuals with severe acute COVID-19 symptoms are more likely to experience long-haul effects. However, even those with mild or asymptomatic cases can develop persistent symptoms. 
- Age: While long COVID affects individuals of all ages, it is more commonly reported in adults aged 30 to 60. A new study of more than 800,000 people has found that in the U.S., COVID “long haulers” were more likely to be older and female, with more chronic conditions than people in a comparison group who — after getting COVID 
- Gender: Research suggests that women may be slightly more prone to long-haul COVID, though the reasons remain unclear. 
- Pre-Existing Conditions: Individuals with underlying health conditions, such as asthma, allergies, autoimmune diseases, and obesity, may be at a higher risk of experiencing long-term symptoms. 
III. Unraveling the Mysteries of Long COVID
Understanding the mechanisms behind long COVID remains a challenge for medical researchers. Possible factors contributing to long-haul symptoms include:
1. MONOCYTE POLARIZATION: Monocytes play a crucial role in the immune response to Covid-19, undergoing different functions throughout their life cycle. These functions include attacking perceived threats to the body, repairing damaged tissues, and patrolling for signs of danger. Understanding monocyte polarization is essential in comprehending the immune response and developing strategies to combat the virus effectively. The disruption of the normal life cycle of monocytes and macrophages can lead to a disorganized immune response that favors chronic inflammation. This chronic inflammation is often observed in Long Covid, contributing to persistent symptoms and complications. Understanding the mechanisms of monocyte polarization is crucial in addressing the underlying inflammation and developing targeted treatments for Long Covid. The regulation of monocyte and macrophage life cycles is influenced by ACE2, which helps prevent polarization. Restoring ACE2 activity is crucial in reversing chronic inflammation. Additionally, proper mitochondrial function is essential for the normal life cycles of monocytes and macrophages due to their high energy demands. Therefore, providing mitochondrial support plays a significant role in correcting monocyte/macrophage polarization and reducing chronic inflammation associated with post-Covid conditions such as Long Covid. ,
2. AUTO-ANTIBODIES: In some cases, the immune response becomes dysregulated and auto-antibodies are produced. Auto-antibodies are antibodies that mistakenly target the body’s own proteins instead of foreign molecules. In the context of Covid-19, auto-antibodies may recognize and bind to host proteins, leading to immune-mediated damage and inflammation. These auto-antibodies can contribute to various post-Covid conditions and complications, further complicating the immune response and potentially causing long-lasting effects. Vaccine-induced antibodies have some similarities but many differences with natural Covid antibodies. Decreasing inflammation is therefore the best protection against covid-induced autoimmunity.,
3. T-CELL IMPAIRMENT: T-lymphocytes play a crucial role in coordinating the immune response against pathogens like SARS-CoV-2. However, the virus can directly invade and impair T-lymphocytes, compromising their ability to eliminate the virus from the body effectively. This impairment not only makes it more challenging for the body to fight off the infection but also increases the risk of reinfection and the development of auto-antibodies. It is important to support T-cell function and find ways to mitigate their impairment to enhance the overall immune response against Covid-19. Indeed, restoring T-cell function is crucial for resolving Long Covid and addressing the issue of viral persistence. T-cells, particularly T-effector memory (TEM) cells, play a vital role in eradicating viral infections and mounting an effective immune response to vaccines. However, mitochondrial dysfunction can impair T-cell function, undermining their ability to eliminate persistent viral infections. Additionally, there have been discussions among researchers about the potential reactivation of latent infections by other viruses as a result of Covid-19. Addressing mitochondrial dysfunction and monitoring potential viral reactivations are essential steps in managing Long Covid and promoting recovery. It is intriguing to note that the reactivation of the Epstein-Barr Virus (EBV) in Long Covid may be directly linked to TEM cell dysfunction. TEM cells are important in controlling latent viruses, including EBV, in their dormant states. The activity of TEM cells is significantly influenced by the composition of bacteria residing in the gastrointestinal tract, known as the gut microbiome. Therefore, restoring mitochondrial function and promoting a healthy gut microbiome are essential components of an effective protocol aimed at enhancing TEM cell function post-Covid-19. By addressing these factors, it may be possible to mitigate EBV reactivation and promote recovery from Long Covid.,
4. VIRAL PERSISTENCE: In cases of Long Covid, the persistent presence of the SARS-CoV-2 virus in the body seems to contribute to the ongoing inflammatory response. Studies have shown that the virus can persist in various parts of the body for several months following the initial infection. Many researchers specializing in this area believe that the gastrointestinal tract is a primary site of viral persistence, which further connects this strand to the subsequent topic, Gut Microbial Dysbiosis. It is important to investigate and address viral persistence as it may play a significant role in the manifestation and persistence of Long Covid symptoms.,,
5. MICROBIAL DYSBIOSIS: Dysbiosis refers to an imbalance or disruption in the microbiome, which is the diverse community of microorganisms that inhabit our body. These microorganisms, which include bacteria, viruses, fungi, and other microbes, are found on every surface of our body. The majority of these microorganisms, around 99%, reside in the gastrointestinal tract, particularly the large intestine. Dysbiosis can lead to an altered composition of the microbiome and can have various negative effects on our health and immune system function. In Long Covid, dysbiosis of the gut microbiome has been associated with persistent symptoms and may play a role in exacerbating inflammation and immune dysfunction. Addressing dysbiosis through interventions aimed at restoring a healthy balance of gut microorganisms is an important aspect of managing Long Covid symptoms.,
6. MAST CELL ACTIVATION: refers to the process where mast cells, primitive cells of the immune system found in different tissues and organs, release various chemical mediators. These mediators, including histamine, can have diverse effects on the body. They can cause the narrowing or widening of blood vessels and increase their permeability, leading to fluid leakage from blood vessels and membranes. The activation of mast cells can contribute to symptoms commonly associated with allergies and other inflammatory responses. Understanding this aspect of Long Covid can provide insights into the physiological changes occurring in individuals experiencing these symptoms. Mast cell activation can lead to a variety of symptoms such as pain, swelling, redness, shortness of breath, diarrhea, and fluctuations in blood pressure. These mediators can also play a role in conditions like migraine headaches, asthma, and irritable bowel syndrome. Additionally, mast cell mediators can influence the function of other immune cells, such as lymphocytes. In the context of Covid-19, the virus can trigger mast cell activation. In some individuals, these activated mast cells may continue to release mediators even after the initial trigger has subsided. This sustained activation of mast cells may contribute to the development or worsening of microthrombosis and endothelitis seen in Long Covid cases. Understanding this aspect of the immune response is important for identifying potential treatment strategies. When patients being treated for Long Covid exhibit any of the problems mentioned earlier, or do not respond as expected to treatments, or experience unusual adverse reactions to treatments that should be helpful, mast cell activation is often the underlying cause. Identifying and addressing mast cell activation can be crucial in improving the overall condition of these patients. ,,
7. MICROTHROMBOSIS: refers to the formation of tiny blood clots that can obstruct capillaries, leading to a further restriction of blood flow. In the context of Long Covid, microthrombosis exacerbates endothelitis and hampers proper blood circulation.It is important to note that the mechanism behind microthrombosis in Long Covid differs from the formation of regular blood clots. As a result, conventional anti-clotting measures may not be as effective in addressing this specific complication.,
8. ENDOTHELITIS: Refers to the inflammation of the cells that line your blood vessels, known as the endothelium. This inflammation can result in the loss of small blood vessels such as capillaries and stiffness in larger blood vessels like veins and arteries. Endothelitis can impede proper blood flow and oxygen delivery to tissues. Furthermore, endothelitis leads to the second strand of the web called microthrombosis. Microthrombosis involves the formation of tiny blood clots within the blood vessels. Restoring ACE2 levels can help alleviate both endothelitis and microthrombosis, but additional measures may be necessary.Many of these measures are actions that individuals can take themselves to address these complications effectively.,
Understanding Long Covid requires a detailed analysis of its interconnected components. By unraveling these complexities, healthcare providers can develop targeted treatments that address the underlying mechanisms and improve patient outcomes.
Understanding how Long Covid works involves recognizing the interconnectedness of various dysfunctions. The eight dysfunctions mentioned (mast cell activation, monocyte/macrophage polarization, T-cell impairment, viral persistence, autoantibodies, ACE2 damage, GI tract vulnerability, endothelitis, and microthrombosis) reinforce each other and contribute to the overall impact of Long Covid.
For example, mast cell activation or monocyte/macrophage polarization can lead to T-cell impairment. T-cell impairment, in turn, allows viral persistence to worsen. Additionally, autoantibodies may cause damage to ACE2 receptors, making the gastrointestinal (GI) tract more susceptible to dysbiosis. Furthermore, endothelitis and microthrombosis working together can create significant disruption.
By addressing these interconnected dysfunctions comprehensively in the treatment approach for Long Covid, it becomes possible to mitigate their collective impact and promote better recovery outcomes.
Through ongoing research, heightened awareness, and empathetic healthcare, our goal is to offer a ray of hope and enhanced prospects for long-haul COVID patients. Join us in this endeavor by scheduling a COVID Long Haul treatment consultation with our Text2MD expert physicians, who are dedicated to guiding patients on their path to recovery and regaining a high quality of life.
- CDC Long COVID or Post-COVID Conditions
- HEALTH AFFAIRSVOL. 42, NO. 3: PUBLIC HEALTH DURING COVID-19 & MORE, Demographic And Clinical FactorsAssociated With Long COVID Zirui Song and Mia Giuriato
- Integr Med (Encinitas). 2021 Dec; 20(6): 36–37.
- Front Immunol. 2023; 14: 1151780.
- Nat Commun. 2021 Sep 14;12(1):5417. doi: 10.1038/s41467-021-25509-3
- European Respiratory Journal 2023 61: 2200970; DOI: 10.1183/13993003.00970-2022
- Prolonged T-cell activation and long COVID symptoms independently associate with severe COVID-19 at 3 months eLife 12:e85009.
- Visvabharathy L, Hanson BA, Orban ZS, Lim PH, Palacio NM, Jimenez M, Clark JR, Graham EL, Liotta EM, Tachas G, Penaloza-MacMaster P, Koralnik IJ. T cell responses to SARS-CoV-2 in people with and without neurologic symptoms of long COVID. medRxiv [Preprint]. 2022 Oct 21:2021.08.08.21261763. doi: 10.1101/2021.08.08.21261763. PMID: 34401886; PMCID: PMC8366804.
- Benjamin Chen, Boris Julg, Sindhu Mohandas, Steven B Bradfute, RECOVER Mechanistic Pathways Task Force (2023) Viral persistence, reactivation, and mechanisms of long COVID eLife 12:e86015
- Buonsenso D, Piazza M, Boner AL, Bellanti JA. Long COVID: A proposed hypothesis-driven model of viral persistence for the pathophysiology of the syndrome. Allergy Asthma Proc. 2022 May 1;43(3):187-193. doi: 10.2500/aap.2022.43.220018. PMID: 35524358; PMCID: PMC9106095.
- Association of SARS-CoV-2 infection and persistence with long COVIDChengliang Yang,Hedi Zhao,Estefanía Espín,Scott J Tebbutt, The Lancet Respiratory Medicine,June 2023
- Zhang D, Zhou Y, Ma Y, Chen P, Tang J, Yang B, Li H, Liang M, Xue Y, Liu Y, Zhang J, Wang X. Gut Microbiota Dysbiosis Correlates With Long COVID-19 at One-Year After Discharge. J Korean Med Sci. 2023 Apr 17;38(15):e120. doi: 10.3346/jkms.2023.38.e120. PMID: 37069814; PMCID: PMC10111044.
- Front. Immunol., 08 March 2023 Sec. Microbial Immunology Volume 14 – 2023 | https://doi.org/10.3389/fimmu.2023.1080043
- Sumantri S, Rengganis I. Immunological dysfunction and mast cell activation syndrome in long COVID. Asia Pac Allergy. 2023 Mar;13(1):50-53. doi: 10.5415/apallergy.0000000000000022. Epub 2023 Apr 28. PMID: 37389095; PMCID: PMC10166245.
- Weinstock LB, Brook JB, Walters AS, Goris A, Afrin LB, Molderings GJ. Mast cell activation symptoms are prevalent in Long-COVID. Int J Infect Dis. 2021 Nov;112:217-226. doi: 10.1016/j.ijid.2021.09.043. Epub 2021 Sep 23. PMID: 34563706; PMCID: PMC8459548.
- Mast cell activation is associated with post-acute COVID-19 syndrome,Joshua B. Wechsler, Melina Butuci, Alan Wong, Amol P. Kamboj, Bradford A. Youngblood First published: 25 November 2021 https://doi.org/10.1111/all.15188
- Kell DB, Laubscher GJ, Pretorius E. A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications. Biochem J. 2022 Feb 17;479(4):537-559. doi: 10.1042/BCJ20220016. PMID: 35195253; PMCID: PMC8883497.
- Nicolai L, Kaiser R, Stark K. Thromboinflammation in long COVID-the elusive key to postinfection sequelae? J Thromb Haemost. 2023 Aug;21(8):2020-2031. doi: 10.1016/j.jtha.2023.04.039. Epub 2023 May 11. PMID: 37178769; PMCID: PMC10174338.
- Vassiliou AG, Vrettou CS, Keskinidou C, Dimopoulou I, Kotanidou A, Orfanos SE. Endotheliopathy in Acute COVID-19 and Long COVID. Int J Mol Sci. 2023 May 4;24(9):8237. doi: 10.3390/ijms24098237. PMID: 37175942; PMCID: PMC10179170.
- Xu, Sw., Ilyas, I. & Weng, Jp. Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies. Acta Pharmacol Sin 44, 695–709 (2023). https://doi.org/10.1038/s41401-022-00998-0